These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 32977677)

  • 1. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
    Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
    Front Immunol; 2018; 9():2359. PubMed ID: 30369931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
    Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
    Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How antigen specificity directs regulatory T-cell function: self, foreign and engineered specificity.
    Hoeppli RE; MacDonald KG; Levings MK; Cook L
    HLA; 2016 Jul; 88(1-2):3-13. PubMed ID: 27256587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy With Regulatory T Cells: A Beneficial Alliance.
    Biswas M; Kumar SRP; Terhorst C; Herzog RW
    Front Immunol; 2018; 9():554. PubMed ID: 29616042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.
    Chae WJ; Bothwell ALM
    Front Immunol; 2018; 9():303. PubMed ID: 29503652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
    Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
    J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologia Futura: Emerging antigen-specific therapies for autoimmune diseases.
    Sármay G
    Biol Futur; 2021 Mar; 72(1):15-24. PubMed ID: 34554499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
    Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases.
    Herkel J
    Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treg Therapies Revisited: Tolerance Beyond Deletion.
    Pilat N; Sprent J
    Front Immunol; 2020; 11():622810. PubMed ID: 33633742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAR Treg: A new approach in the treatment of autoimmune diseases.
    Beheshti SA; Shamsasenjan K; Ahmadi M; Abbasi B
    Int Immunopharmacol; 2022 Jan; 102():108409. PubMed ID: 34863655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
    Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
    J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-based autoimmune disease therapy.
    Serra P; Santamaria P
    Clin Immunol; 2015 Sep; 160(1):3-13. PubMed ID: 25704658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.
    Lüth S; Huber S; Schramm C; Buch T; Zander S; Stadelmann C; Brück W; Wraith DC; Herkel J; Lohse AW
    J Clin Invest; 2008 Oct; 118(10):3403-10. PubMed ID: 18802476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.